68 related articles for article (PubMed ID: 19905900)
1. Hormone replacement therapy after breast cancer: attitudes of women eligible in a randomized trial.
Wallberg B; von Schoultz E; Bolund C; Bergh J; Wilking N
Climacteric; 2009 Dec; 12(6):478-89. PubMed ID: 19905900
[TBL] [Abstract][Full Text] [Related]
2. Menopausal hormone therapy after breast cancer: the Stockholm randomized trial.
von Schoultz E; Rutqvist LE;
J Natl Cancer Inst; 2005 Apr; 97(7):533-5. PubMed ID: 15812079
[TBL] [Abstract][Full Text] [Related]
3. Estrogen replacement therapy after treatment for localized breast carcinoma. Patient responses and opinions.
Vassilopoulou-Sellin R; Klein MJ
Cancer; 1996 Sep; 78(5):1043-8. PubMed ID: 8780542
[TBL] [Abstract][Full Text] [Related]
4. Increased risk of recurrence after hormone replacement therapy in breast cancer survivors.
Holmberg L; Iversen OE; Rudenstam CM; Hammar M; Kumpulainen E; Jaskiewicz J; Jassem J; Dobaczewska D; Fjosne HE; Peralta O; Arriagada R; Holmqvist M; Maenpaa J;
J Natl Cancer Inst; 2008 Apr; 100(7):475-82. PubMed ID: 18364505
[TBL] [Abstract][Full Text] [Related]
5. National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1-3, 2000.
National Institutes of Health Consensus Development Panel
J Natl Cancer Inst Monogr; 2001; (30):5-15. PubMed ID: 11773285
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant therapy for breast cancer.
NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer risk with postmenopausal hormonal treatment.
Collins JA; Blake JM; Crosignani PG
Hum Reprod Update; 2005; 11(6):545-60. PubMed ID: 16150813
[TBL] [Abstract][Full Text] [Related]
8. The thoughts of breast cancer survivors regarding the need for starting hormone replacement therapy.
Trinh XB; Peeters F; Tjalma WA
Eur J Obstet Gynecol Reprod Biol; 2006 Feb; 124(2):250-3. PubMed ID: 16144734
[TBL] [Abstract][Full Text] [Related]
9. Randomized prospective trial of estrogen-replacement therapy in women with a history of breast cancer.
Vassilopoulou-Sellin R; Theriault RL
J Natl Cancer Inst Monogr; 1994; (16):153-9. PubMed ID: 7999459
[TBL] [Abstract][Full Text] [Related]
10. Is HRT justified for symptom management in women at higher risk of developing breast cancer?
Rippy L; Marsden J
Climacteric; 2006 Dec; 9(6):404-15. PubMed ID: 17085372
[TBL] [Abstract][Full Text] [Related]
11. Estrogen replacement therapy for menopausal women with a history of breast carcinoma: results of a 5-year, prospective study.
Vassilopoulou-Sellin R; Cohen DS; Hortobagyi GN; Klein MJ; McNeese M; Singletary SE; Smith TL; Theriault RL
Cancer; 2002 Nov; 95(9):1817-26. PubMed ID: 12404273
[TBL] [Abstract][Full Text] [Related]
12. Women's views of optimal risk communication and decision making in general practice consultations about the menopause and hormone replacement therapy.
Walter FM; Emery JD; Rogers M; Britten N
Patient Educ Couns; 2004 May; 53(2):121-8. PubMed ID: 15140450
[TBL] [Abstract][Full Text] [Related]
13. An informed decision? Breast cancer patients and their knowledge about treatment.
Fagerlin A; Lakhani I; Lantz PM; Janz NK; Morrow M; Schwartz K; Deapen D; Salem B; Liu L; Katz SJ
Patient Educ Couns; 2006 Dec; 64(1-3):303-12. PubMed ID: 16860523
[TBL] [Abstract][Full Text] [Related]
14. Postmenopausal hormone therapy: cardiovascular risks.
Prescrire Int; 2003 Apr; 12(64):65-9. PubMed ID: 12674130
[TBL] [Abstract][Full Text] [Related]
15. Are older breast carcinoma survivors willing to take hormone replacement therapy?
Ganz PA; Greendale GA; Kahn B; O'Leary JF; Desmond KA
Cancer; 1999 Sep; 86(5):814-20. PubMed ID: 10463980
[TBL] [Abstract][Full Text] [Related]
16. Hormone replacement therapy and breast cancer risk in Kyushu University Hospital: supporting the Women's Health Initiative study.
Nozaki M; Koera K; Nagata H; Nakano H
J Obstet Gynaecol Res; 2004 Aug; 30(4):297-302. PubMed ID: 15238106
[TBL] [Abstract][Full Text] [Related]
17. A single mathematical model predicts physicians' recommendations and postmenopausal women's decisions to participate in a clinical trial to prevent breast cancer or coronary heart disease.
Veit CT
Med Decis Making; 2004; 24(4):330-50. PubMed ID: 15271272
[TBL] [Abstract][Full Text] [Related]
18. A tale of two studies: the importance of setting, subjects and context in two randomized, controlled trials of a web-based decision support for perimenopausal and postmenopausal health decisions.
Saver BG; Gustafson D; Taylor TR; Hawkins RP; Woods NF; Dinauer S; Casey S; MacLaren-Loranger A
Patient Educ Couns; 2007 May; 66(2):211-22. PubMed ID: 17317080
[TBL] [Abstract][Full Text] [Related]
19. Psychological and clinical factors implicated in decision making about a trial of low-dose tamoxifen in hormone replacement therapy users.
Rondanina G; Puntoni M; Severi G; Varricchio C; Zunino A; Feroce I; Bonanni B; Decensi A
J Clin Oncol; 2008 Mar; 26(9):1537-43. PubMed ID: 18349406
[TBL] [Abstract][Full Text] [Related]
20. Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin.
Anderson GL; Chlebowski RT; Rossouw JE; Rodabough RJ; McTiernan A; Margolis KL; Aggerwal A; David Curb J; Hendrix SL; Allan Hubbell F; Khandekar J; Lane DS; Lasser N; Lopez AM; Potter J; Ritenbaugh C
Maturitas; 2006 Sep; 55(2):103-15. PubMed ID: 16815651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
